Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000921895-20-003084)

Filing Details

Accession Number:: 0000921895-20-003084
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-20 19:46:10
Reporting Period:: 2020-11-18

Accepted Time:: 2020-11-20 19:46:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1497504	Plx Pharma Inc.	PLXP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1319551	J Michael Valentino	9 Fishers Lane Suite E Sparta NJ 07871	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-18	264,900	$3.79	461,690	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2020-11-18	160,000	$0.00	160,000	$5.15
Common Stock	Warrants (right to buy)	Acquisiton	2020-11-18	291,390	$0.00	291,390	$4.31

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
160,000		2030-11-18	No	4	A	Direct
291,390	2020-11-18	2025-11-18	No	4	P	Direct

Footnotes

Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan.
These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.
Issued pursuant to a private placement in connection with the purchase of immediately serparable units comprised of common stock and warrants.